Historical salary details - Dr. Suzanne L. Bruhn, PhD, Independent Director, Vigil Neuroscience Inc
Dr. Suzanne L. Bruhn, PhD is the Independent Director of Vigil Neuroscience Inc. They also hold 3 other positions in Mind Medicine Inc, Pliant Therapeutics Inc and Travere Therapeutics Inc.
Dr. Suzanne L. Bruhn, Phd
Independent Director
-
Gross Remuneration
-
Current Company
Vigil Neuroscience Inc
| YEAR | COMPANY | POSITION | SALARY | INCREMENT |
|---|---|---|---|---|
| 2024 | Vigil Neuroscience Inc | Independent Director | - | - |
| 2024 | Mind Medicine Inc | Independent Director | - | - |
| 2024 | Pliant Therapeutics Inc | Independent Director | - | - |
| 2024 | Travere Therapeutics Inc | Independent Director | - | - |
| 2023 | Pliant Therapeutics Inc | Independent Director | 277.2 K | 140.9 % |
| 2023 | Mind Medicine Inc | Independent Director | 148.7 K | -68.1 % |
| 2023 | Vigil Neuroscience Inc | - | 138.5 K | 11.8 % |
| 2023 | Travere Therapeutics Inc | Independent Director | - | - |
| 2022 | Mind Medicine Inc | Independent Director | 466.8 K | - |
| 2022 | Travere Therapeutics Inc | Independent Director | 319.1 K | 14.0 % |
| 2022 | Vigil Neuroscience Inc | Independent Director | 123.9 K | - |
| 2022 | Pliant Therapeutics Inc | Independent Director | 115.1 K | -60.1 % |
| 2022 | Avalo Therapeutics Inc | Independent Director | 27.4 K | -82.7 % |
| 2021 | Pliant Therapeutics Inc | Independent Director | 288.3 K | 137.7 % |
| 2021 | Travere Therapeutics Inc | Independent Director | 279.9 K | -21.3 % |
| 2021 | Avalo Therapeutics Inc | Lead Independent Director | 158.4 K | 1.7 % |
| 2020 | Travere Therapeutics Inc | Independent Director | 355.7 K | - |
| 2020 | Spyre Therapeutics Inc. | Independent Director | 187.9 K | 89.2 % |
| 2020 | Avalo Therapeutics Inc | Independent Director | 155.8 K | - |
| 2020 | Pliant Therapeutics Inc | Independent Director | 121.3 K | 93.4 % |
| 2019 | Spyre Therapeutics Inc. | Independent Director | 99.3 K | -45.0 % |
| 2019 | Pliant Therapeutics Inc | Independent Director | 62.7 K | - |
| 2019 | Avalo Therapeutics Inc | Independent Director | - | - |
| 2019 | Travere Therapeutics Inc | Independent Director | - | - |
| 2018 | Spyre Therapeutics Inc. | Independent Director | 180.6 K | -46.1 % |
| 2017 | Spyre Therapeutics Inc. | Independent Director | 334.9 K | - |
| 2016 | Spyre Therapeutics Inc. | Independent Director | - | - |